Peptide Research Stacks
Curated peptide combinations used in research - with composition and pathway for each. No human clinical trials exist for most combinations. For research purposes only.
Research purposes only. These are reference protocols, not medical advice. No human clinical trials exist for most combinations. Always follow applicable regulations in your jurisdiction.
Research Stacks
Select a stack based on your research goal. Each combines peptides acting on related pathways. Composition is provided as reference only - no use, exposure or schedule is response.
GH Axis Blend
Peptides
Protocol
The most studied GH secretagogue combination. CJC-1295 extends Ipamorelin's GH pulse.
Tissue Repair Blend
Peptides
Protocol
No human clinical trials exist for this combination. Most widely researched combo for connective tissue repair.
GLP-1 Receptor Blend
Peptides
Protocol
Single-agent protocol. GIP + GLP-1 dual agonist. Based on SURMOUNT-1 trial exposure protocol.
Cellular Longevity Blend
Peptides
Protocol
Combines GH pulse support with telomere-related Epithalon protocols from Khavinson's research.
Neuro Blend
Peptides
Protocol
Russian clinical peptides often used together: Semax for focus/BDNF, Selank for anxiety reduction.
Immune Blend
Peptides
Protocol
FDA Orphan Drug designation. Well-established fixed 1.6 mg exposure protocol.
Semaglutide Reference Blend
Peptides
Protocol
STEP trial fixed exposure. Most studied GLP-1 agonist for weight management.
Frequently Asked Questions
Understanding peptide stacking principles and safety.
What is a peptide research stack?
A peptide stack is a combination of two or more peptides designed to work synergistically. Stacking allows researchers to target multiple pathways simultaneously - for example, combining a GH-releasing peptide (Ipamorelin) with a GHRH analog (CJC-1295) to amplify GH pulse amplitude and duration beyond either peptide alone.
Are these stacks proven in humans?
Most blends shown here have limited or no human clinical trial data. Their composition is derived from animal studies, observational reports, and practitioner consensus. Individual peptides have varying levels of human evidence: Semaglutide and Tirzepatide have robust Phase 3 trial data (STEP, SURMOUNT). BPC-157 and TB-500 have only animal data. Always consult current research and local regulations.
How do I choose which stack to try?
Choose based on the pathway you are studying. GH-axis blends act on growth hormone secretion. Recovery stacks (Recovery & Repair) target tissue healing. Weight loss stacks (GLP-1, Semaglutide) target appetite and metabolism. Cognitive stacks target BDNF and mood. Start with lower doses, monitor response, and adjust over 4-8 weeks.
Can I modify these stacks or combine peptides differently?
These are reference compositions, not prescriptions and not recommendations for use. Synergistic peptides work well together - GH secretagogues + GHRH analogs, recovery peptides + antiinflammatories, GLP-1 agents + lifestyle. Test one variable at a time to identify what works for your protocol.
Research Tools
Complete your research workflow.